| A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1 Y Miki, J Swensen, D Shattuck-Eidens, PA Futreal, K Harshman, ... Science 266 (5182), 66-71, 1994 | 8580 | 1994 |
| Triple-negative breast cancer: clinical features and patterns of recurrence R Dent, M Trudeau, KI Pritchard, WM Hanna, HK Kahn, CA Sawka, ... Clinical cancer research 13 (15), 4429-4434, 2007 | 6113 | 2007 |
| Identification of the breast cancer susceptibility gene BRCA2 R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, ... Nature 378 (6559), 789-792, 1995 | 4941 | 1995 |
| Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ... The American Journal of Human Genetics 72 (5), 1117-1130, 2003 | 4865 | 2003 |
| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ... The American Journal of Human Genetics 62 (3), 676-689, 1998 | 3984 | 1998 |
| Localization of a Breast Cancer Susceptibility Gene, BRCA2, to Chromosome 13q12-13 R Wooster, SL Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, ... Science 265 (5181), 2088-2090, 1994 | 2872 | 1994 |
| Risks of cancer in BRCA1-mutation carriers D Ford, DF Easton, DT Bishop, SA Narod, DE Goldgar The Lancet 343 (8899), 692-695, 1994 | 2486 | 1994 |
| Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van't Veer, ... New England Journal of Medicine 346 (21), 1616-1622, 2002 | 1883 | 2002 |
| Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L Van’t Veer, ... Journal of clinical oncology 22 (6), 1055-1062, 2004 | 1550 | 2004 |
| Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination E Warner, DB Plewes, KA Hill, PA Causer, JT Zubovits, RA Jong, ... Jama 292 (11), 1317-1325, 2004 | 1507 | 2004 |
| A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 RJ Hung, JD McKay, V Gaborieau, P Boffetta, M Hashibe, D Zaridze, ... Nature 452 (7187), 633-637, 2008 | 1493 | 2008 |
| Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. H Meijers-Heijboer, A Van den Ouweland, J Klijn, M Wasielewski, ... Nature genetics 31 (1), 2002 | 1416 | 2002 |
| BRCA1 and BRCA2: 1994 and beyond SA Narod, WD Foulkes Nature Reviews Cancer 4 (9), 665-676, 2004 | 1335 | 2004 |
| Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer HA Risch, JR McLaughlin, DEC Cole, B Rosen, L Bradley, E Kwan, ... The American Journal of Human Genetics 68 (3), 700-710, 2001 | 1248 | 2001 |
| Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015 | 1226 | 2015 |
| Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial AB Miller, C Wall, CJ Baines, P Sun, T To, SA Narod Bmj 348, 2014 | 1082 | 2014 |
| BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, ... Jama 275 (24), 1885-1892, 1996 | 1058 | 1996 |
| Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin–cohort study in Ontario, Canada HA Risch, JR McLaughlin, DEC Cole, B Rosen, L Bradley, I Fan, J Tang, ... Journal of the National Cancer Institute 98 (23), 1694-1706, 2006 | 933 | 2006 |
| Oral contraceptives and the risk of hereditary ovarian cancer SA Narod, H Risch, R Moslehi, A Dørum, S Neuhausen, H Olsson, ... New England Journal of Medicine 339 (7), 424-428, 1998 | 875 | 1998 |
| Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers TR Rebbeck, AM Levin, A Eisen, C Snyder, P Watson, L Cannon-Albright, ... Journal of the National Cancer Institute 91 (17), 1475-1479, 1999 | 842 | 1999 |
